Grifols S A Financials

GRFS

Source SEC Filings (10-K/10-Q) Updated Apr 17, 2026 Currency USD FYE April

This page shows Grifols S A (GRFS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GRFS FY2025 2026-04-22

Thin-margin profitability is being supported by a high-turnover asset base, while liabilities above assets keep liquidity management central.

2.9% net margin still produced a respectable 7.4% return on assets because revenue of $206M sits on only $81M of assets, implying roughly 2.5x asset turnover. That efficiency matters because the balance sheet is still tight: current assets cover only about 57.5% of current liabilities, so operational cash timing matters more than the small accounting profit suggests.

With $103M of liabilities against $81M of assets, the company is operating without much balance-sheet cushion; reported earnings are positive, but they have not yet rebuilt a strong net asset base. That makes the business more dependent on keeping obligations well managed than the income line alone would imply.

Only $8M is listed as long-term debt, which means the liability load is not primarily a classic term-borrowing story. Combined with the 0.6x current ratio, the pressure appears to sit more in broader obligations and near-term funding needs than in large long-dated borrowings.

Financial Health Signals

Financial Profile 1/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Grifols S A's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

Grifols S A's current ratio of 0.57 is below the typical benchmark, resulting in a score of 6/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$206.0M

Grifols S A generated $206.0M in revenue in fiscal year 2025.

EBITDA

N/A

Net Income

$6.0M

Grifols S A reported $6.0M in net income in fiscal year 2025.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

426M

Grifols S A had 426M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

2.9%

Grifols S A's net profit margin was 2.9% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

GRFS Income Statement

Metric	FY25
Revenue	$206.0M
Cost of Revenue	N/A
Gross Profit	N/A
R&D Expenses	N/A
SG&A Expenses	N/A
Operating Income	N/A
Interest Expense	N/A
Income Tax	N/A
Net Income	$6.0M
EPS (Diluted)	N/A

GRFS Balance Sheet

Metric	FY25
Total Assets	$81.0M
Current Assets	$27.0M
Cash & Equivalents	N/A
Inventory	N/A
Accounts Receivable	N/A
Goodwill	N/A
Total Liabilities	$103.0M
Current Liabilities	$47.0M
Long-Term Debt	$8.0M
Total Equity	-$28.0M
Retained Earnings	N/A

GRFS Financial Ratios

Metric	FY25
Gross Margin	N/A
Operating Margin	N/A
Net Margin	2.9%
Return on Equity	N/A
Return on Assets	7.4%
Current Ratio	0.57
Debt-to-Equity	-0.29
FCF Margin	N/A

Note: Shareholder equity is negative (-$28.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.57), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

ORGANON & CO OGN

$3.5B

Elanco Animal Health ELAN

$10.4B

Biogen Inc BIIB

$27.7B

Pfizer PFE

$147.0B

Sanofi FR SNY

$106.8B

Frequently Asked Questions

What is Grifols S A's annual revenue?

Grifols S A (GRFS) reported $206.0M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Grifols S A profitable?

Yes, Grifols S A (GRFS) reported a net income of $6.0M in fiscal year 2025, with a net profit margin of 2.9%.

What is Grifols S A's net profit margin?

Grifols S A (GRFS) had a net profit margin of 2.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What are Grifols S A's total assets?

Grifols S A (GRFS) had $81.0M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Grifols S A have outstanding?

Grifols S A (GRFS) had 426M shares outstanding as of fiscal year 2025.

What is Grifols S A's current ratio?

Grifols S A (GRFS) had a current ratio of 0.57 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Grifols S A's debt-to-equity ratio?

Grifols S A (GRFS) had a debt-to-equity ratio of -0.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Grifols S A's return on assets (ROA)?

Grifols S A (GRFS) had a return on assets of 7.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Grifols S A's debt-to-equity ratio negative or unusual?

Grifols S A (GRFS) has negative shareholder equity of -$28.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Grifols S A?

Grifols S A (GRFS) scores 1 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.